GeneDx Holdings Corp. Class A Common Stock (WGS)
NASDAQ
Delayed Data
Oct 16, 2026, 01:30 PM
Day's Range
62.4952 wk Range
32.21Overview - WGS - GeneDx Holdings Corp. Class A Common Stock
Key Statistics
Valuation
Enterprise Value
1.93B
P/E (Trailing)
724.63
P/E (Forward)
53.07
PEG Ratio
-2.80
Price / Sales (TTM)
4.17
Price / Book
7.76
EV / EBITDA
-57.34
Profitability
Gross Margin
68.36%
Profit Margin
-23.40%
Operating Margin
-15.21%
Return on Assets
-7.89%
Return on Equity
-40.80%
Ownership
Shares Outstanding
29.80M
Float
20.44M
Short % of Shares Outstanding
36.11%
Held by Insiders
7.71%
Held by Institutions
108.80%
Price stats
Beta
1.96
50-Day Avg
81.77
200-Day Avg
75.01
Dividends
Payout Ratio
0.00%
Analyst Consensus
8 analysts
Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - WGS - GeneDx Holdings Corp. Class A Common Stock
Peers - WGS - GeneDx Holdings Corp. Class A Common Stock
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- WGSNASDAQGeneDx Holdings Corp. Class A Common Stock1.89BMarket Cap-99.70%52-week change724.64P/E (Trailing)-23.40%Profit Margin
- NTRANASDAQNatera, Inc.56.71BMarket Cap+52.06%52-week change-258.91P/E (Trailing)-7.10%Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.44.14BMarket Cap-15.53%52-week change39.61P/E (Trailing)25.03%Profit Margin
- ILMNNASDAQIllumina Inc.39.64BMarket Cap+62.10%52-week change48.98P/E (Trailing)18.33%Profit Margin
- GHNASDAQGuardant Health Inc.21.18BMarket Cap+55.54%52-week change-47.56P/E (Trailing)-38.32%Profit Margin
- MEDPNASDAQMedpace Holdings, Inc.18.25BMarket Cap+7.46%52-week change37.17P/E (Trailing)17.66%Profit Margin
- ICLRNASDAQICON plc12.97BMarket Cap-14.94%52-week change176.99P/E (Trailing)0.32%Profit Margin
Profile Summary - WGS - GeneDx Holdings Corp. Class A Common Stock
About
GeneDx Holdings Corp. Class A Common Stock is the equity security of GeneDx Holdings Corp., a genomics company focused on genetic testing and clinical diagnostics. GeneDx provides pediatric and rare disease testing centered on whole exome and whole genome sequencing, along with data and information services that…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
